: As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer
Bank of America analysts downgraded the stock to neutral from buy.
Bank of America analysts downgraded the stock to neutral from buy.
Recover your password.
A password will be e-mailed to you.